Paoletti Paolo 4
4 · Forma Therapeutics Holdings, Inc., · Filed Jun 24, 2020
Insider Transaction Report
Form 4
Paoletti Paolo
Director
Transactions
- Sale
Enterprise 2 Junior Stock
2020-06-23−25,248→ 0 total - Sale
Enterprise 3 Junior Stock
2020-06-23−9,847→ 0 total - Sale
Enterprise 4 Junior Stock
2020-06-23−10,240→ 0 total - Purchase
Common Stock
2020-06-23+45,553→ 45,553 total - Sale
Enterprise 5 Junior Stock
2020-06-23−14,026→ 0 total
Footnotes (1)
- [F1]Effective immediately upon the closing of the Registrant's initial public offering on June 23, 2020, the reporting person converted (i) 25,248 shares of Enterprise 2 Junior Stock at a conversion rate of 0.8179 shares of common stock per one share of Enterprise 2 Junior Stock, (ii) 9,847 shares of Enterprise 3 Junior Stock at a conversion rate of 0.7822 shares of common stock per one share of Enterprise 3 Junior Stock, (iii) 10,240 shares of Enterprise 4 Junior Stock at a conversion rate of 0.7585 shares of common stock per one share of Enterprise 4 Junior Stock, and (iv) 14,026 shares of Enterprise 5 Junior Stock at a conversion rate of 0.6727 shares of common stock per one share of Enterprise 5 Junior Stock, resulting in his acquisition of 45,553 shares of common stock.